HIV & AIDS news
Mortality rates decrease, chronic disease rates increase among HIV+ ICU patients
The expanded use of antiretrovirals, potent drugs used to treat retroviral infections such as human immunodeficiency virus (HIV), has been linked to significant decreases in hospital mortality rates among severely ill HIV-positive(HIV+) ...
HIV & AIDS
13 hours ago |
not rated yet |
0
Newly discovered breast milk antibodies help neutralize HIV
Antibodies that help to stop the HIV virus have been found in breast milk. Researchers at Duke University Medical Center isolated the antibodies from immune cells called B cells in the breast milk of infected mothers in Malawi, ...
HIV & AIDS
May 22, 2012 |
5 / 5 (3) |
1
|
Reactions to HIV drug have autoimmune cause, reports AIDS journal
Potentially severe hypersensitivity reactions to the anti-HIV drug abacavir occur through an autoimmune mechanism, resulting from the creation of drug-induced immunogens that are attacked by the body's immune system, according ...
HIV & AIDS
May 22, 2012 |
not rated yet |
0
Is the U.S. ready for home HIV tests?
At the pharmacy, you can buy anything from tea kettles to Tylenol. But what if you could buy a rapid HIV test over the counter and test yourself in the privacy of your own home?
HIV & AIDS
May 21, 2012 |
not rated yet |
0
|
Reduced glycerin formulation of tenofovir vaginal gel safe for rectal use
A change in the formulation of tenofovir gel, an anti-HIV gel developed for vaginal use, may make it safer to use in the rectum, suggests a study published online this week in the Journal of Antimicrobial Chemotherapy. In lab ...
HIV & AIDS
May 17, 2012 |
5 / 5 (1) |
0
HIV may afflict almost half Asia-Pacific transgenders: UN
Nearly half of transgender people in the Asia-Pacific region could have HIV as poor healthcare and high-risk lifestyles push infection rates to "critical levels", a UN report said Thursday.
HIV & AIDS
May 16, 2012 |
not rated yet |
0
Clergy can fight HIV on faith-friendly terms
The public health community has long struggled with how best to reduce HIV infection rates among black Americans, which is seven times that of whites. In a new paper in the journal PLoS ONE, a team of phy ...
HIV & AIDS
May 16, 2012 |
not rated yet |
0
FDA panel backs first rapid, take home HIV test
(AP) -- A panel of HIV specialists is recommending that U.S. regulators approve the first over-the-counter HIV test designed to quickly return a result in the privacy of a person's own home, a new option which could expand ...
HIV & AIDS
May 15, 2012 |
not rated yet |
0
Anti-HIV drug tenofovir is safe to take during pregnancy
Pre-birth exposure to the anti-HIV drug tenofovir does not adversely affect pregnancy outcomes and does not increase birth defects, growth abnormalities, or kidney problems in infants born to African women who are HIV positive, ...
HIV & AIDS
May 15, 2012 |
not rated yet |
0
740,000 lives saved: Study documents benefits of AIDS relief program
The U.S. President's Emergency Plan for AIDS Relief, the government's far-reaching health-care foreign aid program, has contributed to a significant decline in adult death rates from all causes in Africa, according to a new ...
HIV & AIDS
May 15, 2012 |
not rated yet |
0
HIV prevention measures must include behavioral strategies to work, says APA
A drug that has been shown to prevent HIV infection in a significant number of cases must be combined with behavioral approaches if the U.S. health care establishment is to succeed in reducing the spread of the virus, according ...
HIV & AIDS
May 14, 2012 |
not rated yet |
0
Botswana makes new pitch for circumcision in AIDS fight
"Should I, shouldn't I?" That's the question that 31-year-old Kabo Moeti ponders as he waits outside a clinic in a Botswana village, where he's considering getting circumcised.
HIV & AIDS
May 14, 2012 |
not rated yet |
0
FDA reviews first rapid, take-home test for HIV
The Food and Drug Administration is considering approval of the first over-the-counter HIV test that would allow consumers to quickly test themselves for the virus at home, without medical supervision.
HIV & AIDS
May 11, 2012 |
not rated yet |
0
AIDS fight enters new phase with prevention pill
(AP) -- Condoms and other safe-sex practices have accomplished only so much. Now the 30-year battle against AIDS is on the verge of a radical new phase, with the government expected to endorse a once-a-day ...
HIV & AIDS
May 11, 2012 |
not rated yet |
1
FDA panel backs first pill to block HIV infection
The first drug shown to prevent HIV infection won the endorsement of a panel of federal advisers Thursday, clearing the way for a landmark approval in the 30-year fight against the virus that causes AIDS.
HIV & AIDS
May 11, 2012 |
4 / 5 (1) |
0
-
Limits to growth: Scientists identify key metastasis-enabling enzyme
May 22, 2012 |
5 / 5 (3) |
0
-
Seeing is as seeing does: Spatially-structured retinal input in early development of cortical maps
Apr 26, 2012 |
5 / 5 (4) |
1
-
Dreamless nights: Brain activity during nonrapid eye movement sleep
Apr 09, 2012 |
4.4 / 5 (12) |
0
-
Take your time: Neurobiology sheds light on the superiority of spaced vs. massed learning
Mar 28, 2012 |
4.5 / 5 (21) |
3
-
Your brain on 'shrooms: fMRI elucidates neural correlates of psilocybin psychedelic state
Feb 29, 2012 |
4.9 / 5 (42) |
45
More News Stories
Advocates: HIV prevention pill could save lives
(AP) -- A pill to prevent HIV infection is already being given to some healthy people, but without government approval, it remains out of reach and too costly for many who need it.
US health advisors mull AIDS prevention pill (Update)
US health advisers on Thursday urged regulators to approve Truvada, made by Gilead Sciences, as the first preventive pill against HIV/AIDS instead of just a treatment for infected people.
FDA review favors first drug for HIV prevention (Update)
(AP) -- A pill that has long been used to treat HIV has moved one step closer to becoming the first drug approved to prevent healthy people from becoming infected with the virus that causes AIDS.
Study confirms early elevated HIV infection risk in some Step Study participants
A long-term follow-up analysis of participants in the Step Study, an international HIV-vaccine trial, has confirmed that certain subgroups of male study participants were at higher risk of becoming infected after receiving ...
T cell-based HIV gene therapy safe over long term
(HealthDay) -- T cell-based gene therapy for HIV seems safe, with no evidence of vector-induced cell immortalization more than a decade after treatment, according to a study published in the May 2 issue of ...
Advocates: HIV prevention pill could save lives
(AP) -- A pill to prevent HIV infection is already being given to some healthy people, but without government approval, it remains out of reach and too costly for many who need it.
US health advisors mull AIDS prevention pill (Update)
US health advisers on Thursday urged regulators to approve Truvada, made by Gilead Sciences, as the first preventive pill against HIV/AIDS instead of just a treatment for infected people.
FDA review favors first drug for HIV prevention (Update)
(AP) -- A pill that has long been used to treat HIV has moved one step closer to becoming the first drug approved to prevent healthy people from becoming infected with the virus that causes AIDS.
Study confirms early elevated HIV infection risk in some Step Study participants
A long-term follow-up analysis of participants in the Step Study, an international HIV-vaccine trial, has confirmed that certain subgroups of male study participants were at higher risk of becoming infected after receiving ...
T cell-based HIV gene therapy safe over long term
(HealthDay) -- T cell-based gene therapy for HIV seems safe, with no evidence of vector-induced cell immortalization more than a decade after treatment, according to a study published in the May 2 issue of ...
Other Spotlight Stories
Find more news articles via sort by date page
